<DOC>
	<DOCNO>NCT01830205</DOCNO>
	<brief_summary>The purpose study assess effect renal function impairment single dose pharmacokinetics Daclatasvir .</brief_summary>
	<brief_title>Pharmacokinetic Safety Study Daclatasvir Patients With Renal Impairment</brief_title>
	<detailed_description>Treatment , Parallel Assignment , Open Label , Non-Randomized , Single Dose Adaptive Design , Pharmacokinetics Study</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Meet renal function criterion one four category Unstable uncontrolled medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>